Lincoln Pharmaceuticals standalone net profit rises 42.73% in the September 2016 quarter
Sales decline 6.72% to Rs 69.82 crore
Net profit of Lincoln Pharmaceuticals rose 42.73% to Rs 7.75 crore in the quarter ended September 2016 as against Rs 5.43 crore during the previous quarter ended September 2015. Sales declined 6.72% to Rs 69.82 crore in the quarter ended September 2016 as against Rs 74.85 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales69.8274.85 -7 OPM %17.6912.26 -PBDT11.037.77 42 PBT10.177.08 44 NP7.755.43 43Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content